Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
36
Number of overlapping holdings
9.2%
% of VHT's 417 holdings also in IHE
97.3%
% of IHE's 38 holdings also in VHT
Overlap by Weight
Sector Drift (VHT minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.0% | 19.2% | 10.0% |
|
JOHNSON & JOHNSON | 4.7% | 22.2% | 4.7% |
|
MERCK & CO. INC. | 3.9% | 4.0% | 3.9% |
|
PFIZER INC | 2.3% | 4.0% | 2.3% |
|
BRISTOL-MYERS SQUIBB CO | 1.9% | 5.5% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
VHT Overweight Relative to IHE
|
UNITEDHEALTH GROUP INC | 9.1% |
|
ABBVIE INC | 4.4% |
|
ABBOTT LABORATORIES | 3.4% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
INTUITIVE SURGICAL INC | 3.1% |
|
DANAHER CORP | 2.6% |
|
AMGEN INC | 2.5% |
|
STRYKER CORP | 2.2% |
|
BOSTON SCIENTIFIC CORP | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
VHT Underweight Relative to IHE
|
JOHNSON & JOHNSON | -17.5% |
|
ELI LILLY & CO | -9.2% |
|
VIATRIS, INC. | -5.1% |
|
CATALENT INC | -4.2% |
|
ROYALTY PHARMA PLC CLASS A | -4.0% |
|
BRISTOL-MYERS SQUIBB CO | -3.6% |
|
INTRA-CELLULAR THERAPIES INC | -3.3% |
|
ZOETIS INC | -3.0% |
 |
JAZZ PHARMACEUTICALS PLC | -3.0% |
|
ELANCO ANIMAL HEALTH, INC. | -2.7% |